ODDB.org: Open Drug Database

MSD Merck Sharp & Dohme AG - HBVAXPRO 40, Injektionssuspension

Swissmedic Registration	00545	Sequence	01
Product name	HBVAXPRO 40	Description	Injektionssuspension
ATC-Classification	J07BC01	ATC-Description	Hepatitis B, Purified Antigen
Introduction of Sequence	18.04.1988

Composition

hepatitidis B viri antigenum ADNr 40 µg, aluminium 0.5 mg ut aluminii hydroxyphosphas sulfas amorphus, borax, natrii chloridum, aqua ad iniectabile q.s. ad suspensionem pro 1 ml corresp. natrium 3.5 mg.

Packungsbestandteile

Galenic Form

Injection suspension

Excipiens

Active Agent	Dose
Hepatitidis b viri Antigenum Adnr	40 µg/ml

BAG: Active Agent	Dose
Vaccinum Hepatitidis b (Adnr) Hbsag	40 mcg

Inactive agents	Dose
Alumine	0.5 mg/ml
Borax
Sodium Chloride

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
001	ampoule(s)	42.09	62.20	B	SL	Yes

2025	©ywesee GmbH